Charles Michaud Jr. - 03 Jan 2024 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role: Vice President, Corporate Controller and Treasurer
Signature: /s/ Paul Alloway, Attorney-in-Fact for Charles Michaud, Jr.
Issuer symbol: QTTB
Transactions as of: 03 Jan 2024
Net transactions value: -$975
Form type: 4
Filing time: 05 Jan 2024, 17:49:06 UTC
Previous filing: 03 Jan 2024
Next filing: 27 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FIXX	Common Stock	Sale	$975	-1,708	-13%	$0.5710	11,598	03 Jan 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
F2	The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.571 to $0.584. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.

Remarks:

Vice President, Corporate Controller and Treasurer